Vitamin D in SARS-CoV-2 infection
Vitamin D in SARS-CoV-2 infection
Decyk et al., 2022 | Rocz Panstw Zakl Hig | Systematic Review
Citation
Decyk Agnieszka, Kobylińska Milena, ... Kurowska Katarzyna. Vitamin D in SARS-CoV-2 infection. Rocz Panstw Zakl Hig. 2022;73(1):5-12. doi:10.32394/rpzh.2022.0191
Abstract
BACKGROUND: Background. SARS-CoV-2 virus is one of the largest RNA viruses, included in the coronavirus group, showing tropism to airway epithelial cells. SARS-CoV-2 causes an acute respiratory infectious disease, Covid-19. According to WHO reports, mortality due to Covid-19 is higher in the elderly and in those burdened with comorbidities such as diabetes, obstructive pulmonary disease, coronary artery disease, cancer, hypertension, hepatitis B, obesity or chronic kidney disease. OBJECTIVE: The aim of the study was to review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection. MATERIAL AND METHOD: A systematic review of studies published from January 1, 2009 to June 31, 2021 has been performed. For this purpose, bibliographic databases such as PubMed and Scopus were searched. The following keywords and combinations were used: Covid-19, vitamin D, 25-hydroxy-vitamin D, vitamin D supplementation, SARS-CoV-2. RESULTS: It has been shown that vitamin D plays an important role in the mechanisms of the innate immunity in the course of the acute respiratory infections. The overlapping factors of the severity of COVID-19 disease, vitamin D deficiency, and the prevalence of obesity, age scare, ethnicity, has led some researchers to hypothesize that vitamin D supplementation may be promising as a preventive or therapeutic measure for COVID-19. CONCLUSIONS: A very important factor that has an immunomodulatory character is vitamin D, the adequate supplementation of which can be a preventive or therapeutic measure in case of SARS-CoV-2 infection, especially in elderly people, with obesity and other chronic diseases.
Key Findings
It has been shown that vitamin D plays an important role in the mechanisms of the innate immunity in the course of the acute respiratory infections. The overlapping factors of the severity of COVID-19 disease, vitamin D deficiency, and the prevalence of obesity, age scare, ethnicity, has led some researchers to hypothesize that vitamin D supplementation may be promising as a preventive or therapeutic measure for COVID-19.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | elderly people |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | hypertension |
MeSH Terms
- Aged
- COVID-19
- Humans
- SARS-CoV-2
- Vitamin D
- Vitamin D Deficiency
- Vitamins
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: vitamin-d-immune
Provenance
- PMID: 35322953
- DOI: 10.32394/rpzh.2022.0191
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09